Robeco trims Gilead stake by 0.5% but holds $513 million
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Robeco Institutional Asset Management cut its Gilead Sciences stake by 0.5%, selling 17,074 shares while retaining 3.44 million shares worth over $513 million. Analyst consensus remains a Moderate Buy, with 22 buy ratings against 5 holds and 1 sell, and an average price target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context